TrialClinical and experimental nephrology2020

Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad: a novel selective urate reabsorption inhibitor.

Hiroyuki Fukase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.